Cypress, CA, September 29, 2011
Dr. Kenneth Kim gave a presentation entitled “Global Development Strategies – Emerging Trends” at the BioKorea 2011 Conference and Exhibition in Coex, Seoul, Korea on September 28, 2011. The conference was supported by the Korean Government in an effort to help the Korean Biotech Industry grow to world-wide prominence. Dr. Kim’s presentation focused on recent industry trends to include Asian Patients in early clinical drug development trials to enable more efficient globalization of later stage trials. He also presented examples of innovative phase I study designs including various Asian groups. There were 20,000 attendees from 500 companies from over 30 countries at the conference.
“BIO KOREA” launched by the Korean government aims to vitalize the bio industry and make Korea one of the top five world bio players by 2016. Marking its sixth anniversary. this year, BIO KOREA cemented itself as a world class bio event. Many Korean major policy makers, government employees, bio industry managers, and domestic and international experts to participated in the conference.
WCCT is a privately owned early phase development contract research organization, conveniently located near 3 major airports in Southern California. WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Immunology. Conducting trials since 1998, WCCT has been audited by the FDA and numerous pharmaceutical and biotechnology companies. WCCT’s location and access to an ethnically diverse population allows for a wide variety of study designs including ethnic bridging. With 150 beds in two locations and over 60,000 square feet, a well-trained and experienced staff, and advanced technological procedures, WCCT brings the highest quality to the pharmaceutical and biotechnology industries. (www.wcct.com)
West Coast Clinical Trials, LLC
Business Development 1-714.252.0783